700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ ReadersThis Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Review Article Open Access
Post-operative period can be very stormy if the patients grapple with intense pain. From time to time various strategies, techniques and drugs have been developed to counter this most feared side effect of surgery but till date no ideal solution lies to this ever predominant problem. In quest of finding an ideal drug, various newer drugs are being developed with wider safety margin and a favourable profile. Liposomal bupivacaine has emerged as one of the newer drugs on this platform of post-op pain relief. However, larger research studies are required before we can really label this promising drug a better post-op analgesic agent.
Bupivacaine, Liposomal bupivacaine, Opioids, Post-op pain, Diagnostics Reviews